In total, the group with Ki-67 expression levels ≤ 5% was composed of pre-cellular (AAH/AIS) (57/64, 89.06%), minimally invasive (46/56, 82.14%), and invasive adenocarcinomas (29/117, 24.79%). This evidence concerns the gene MKI67 and adenocarcinoma.